BGI News More
- BGI Genomics Announces Pricing of Initial Public Offering
- BGI Launches the Latest Desktop Sequencer BGISEQ-50
- International Science Community Welcomes China National GeneBank Opening
- BGI and Clearbridge BioMedics Partner to Develop China CTC Liquid Biopsy Market towards Precision Medicine
- The international Sc2.0 Project is on track to build the world’s first synthetic yeast genome
- Avian-specific conserved genomic elements play important regulatory roles in the macroevolution of avian-specific features
- The Evolution of Chronic Lymphocytic Leukemia Revealed
- BGI involved in publication of the first seahorse genome in Nature
- Leading Health Organizations in Canada and China Teaming up to Accelerate Precision Medicine
- World’s largest genomic organisation to collaborate with leading Queensland researchers
- Ranomics Partners with BGI to Classify Variants of Unknown Significance
- BGI and UW collaborate on precision medicine development
- Chinese innovation : BGI’s code for success
- Prof. Huanming Yang to Receive Membership from Royal Danish Academy of Sciences and Letters
- UW, Chinese genomics group forge new partnership to advance biomedical research
- Mapping more genomes will create a healthcare 'big data revolution'
Tel: +86-755-36307212Email: firstname.lastname@example.org
Utrecht University, University Medical Center Utrecht and BGI Form Partnership
Publish Date: 2011-10-10
Utrecht University, University Medical Center (UMC) Utrecht and BGI signed a formal agreement on 5th October 2011, in the Netherlands to establish partnership in genomics research programs. The next-generation sequencing and bioinformatics platforms of BGI will allow for efficient and accurate research in genomics fields.
Based on the knowledge, expertise and unique strength of each party, this partnership will bring joint innovative projects on large-scale genome sequencing and functional genomics. It is anticipated that the partnership will provide faculty and students at Utrecht University and UMC Utrecht with access to one of the world’s premier genomics and bioinformatics institute and its associated expertise, while for BGI researchers with access to the diverse and abundant research resources and educational expertise of Utrecht University and UMC Utrecht.
Jos van Strijp, Professor of Experimental Microbiology at UMC Utrecht said, “Modern genomics technologies play an increasingly important role in research and application developments. This partnership is the basis for all the institutions with further cooperation in life science researches. On behalf of Utrecht Life Science community, we are delighted with this collaboration.”
Li Ning, CEO of BGI Europe, also expressed his confidence about this partnership, “This collaboration will add immense value to the research of both Utrecht Life Science and BGI. We believe that life science society will obtain great benefits and advances from establishing partnership. We look forward to establishing further collaborations with other institutions in Europe and all over the world.”
About Utrecht Life Sciences
Utrecht Life Sciences (ULS) is a strategic alliance between academic, public and commercial parties in the areas of education, research and innovation in life sciences. ULS acts as a flywheel to create collaborations between partners to promote the health of humans and animals. ULS focuses on "Public Health - One Health" and "Cancer, Stem Cells & Regenerative Medicine". Utrecht Life Sciences is an initiative of Utrecht University, the University Medical Center Utrecht, the Hogeschool Utrecht and Danone. The other partners are: the Hubrecht Institute for Developmental Biology and Stem Cell Research (KNAW), Genmab, GlaxoSmithKline, Immuno Valley, TNO and Utrecht Holdings. ULS is supported by the Province of Utrecht, Utrecht Municipality and the Innovation Task Force Utrecht region. The strategic partners in education, research and entrepreneurship are all located in the Utrecht Science Park.